174 related articles for article (PubMed ID: 16904289)
21. Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins.
Choi JW; Lim S; Oh YS; Kim EK; Kim SH; Kim YH; Heo K; Kim J; Kim JK; Yang YR; Ryu SH; Suh PG
Cell Signal; 2010 Jul; 22(7):1153-61. PubMed ID: 20227493
[TBL] [Abstract][Full Text] [Related]
22. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
23. Interaction of endothelial cell-selective adhesion molecule and MAGI-1 promotes mature cell-cell adhesion via activation of RhoA.
Kimura R; Ishida T; Kuriyama M; Hirata K; Hayashi Y
Genes Cells; 2010 Apr; 15(4):385-96. PubMed ID: 20298433
[TBL] [Abstract][Full Text] [Related]
24. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
Ha JH; Ward JD; Varadarajalu L; Kim SG; Dhanasekaran DN
Cell Signal; 2014 Jan; 26(1):122-32. PubMed ID: 24055910
[TBL] [Abstract][Full Text] [Related]
25. G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production.
Niu J; Profirovic J; Pan H; Vaiskunaite R; Voyno-Yasenetskaya T
Circ Res; 2003 Oct; 93(9):848-56. PubMed ID: 14512443
[TBL] [Abstract][Full Text] [Related]
26. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.
Ward Y; Lake R; Martin PL; Killian K; Salerno P; Wang T; Meltzer P; Merino M; Cheng SY; Santoro M; Garcia-Rostan G; Kelly K
Oncogene; 2013 May; 32(22):2726-38. PubMed ID: 22797060
[TBL] [Abstract][Full Text] [Related]
27. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
[TBL] [Abstract][Full Text] [Related]
28. PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways.
Dunn HA; Ferguson SS
Mol Pharmacol; 2015 Oct; 88(4):624-39. PubMed ID: 25808930
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK.
Dixon RJ; Brunskill NJ
Kidney Int; 1999 Dec; 56(6):2064-75. PubMed ID: 10594782
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad.
Rusovici R; Ghaleb A; Shim H; Yang VW; Yun CC
Biochim Biophys Acta; 2007 Aug; 1770(8):1194-203. PubMed ID: 17544220
[TBL] [Abstract][Full Text] [Related]
31. Activation of Ras-dependent signaling pathways by G(14) -coupled receptors requires the adaptor protein TPR1.
Kwan DH; Yung LY; Ye RD; Wong YH
J Cell Biochem; 2012 Nov; 113(11):3486-97. PubMed ID: 22711498
[TBL] [Abstract][Full Text] [Related]
32. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Ward Y; Lake R; Yin JJ; Heger CD; Raffeld M; Goldsmith PK; Merino M; Kelly K
Cancer Res; 2011 Dec; 71(23):7301-11. PubMed ID: 21978933
[TBL] [Abstract][Full Text] [Related]
33. Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling.
Stam JC; Michiels F; van der Kammen RA; Moolenaar WH; Collard JG
EMBO J; 1998 Jul; 17(14):4066-74. PubMed ID: 9670021
[TBL] [Abstract][Full Text] [Related]
34. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2.
Wu X; Hepner K; Castelino-Prabhu S; Do D; Kaye MB; Yuan XJ; Wood J; Ross C; Sawyers CL; Whang YE
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4233-8. PubMed ID: 10760291
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q).
Xu MY; Porte J; Knox AJ; Weinreb PH; Maher TM; Violette SM; McAnulty RJ; Sheppard D; Jenkins G
Am J Pathol; 2009 Apr; 174(4):1264-79. PubMed ID: 19147812
[TBL] [Abstract][Full Text] [Related]
36. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation.
Shano S; Hatanaka K; Ninose S; Moriyama R; Tsujiuchi T; Fukushima N
Biochim Biophys Acta; 2008 May; 1783(5):748-59. PubMed ID: 18157949
[TBL] [Abstract][Full Text] [Related]
37. Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.
Wang Y; Chen Y; Li Y; Lan T; Qian H
Mol Med Rep; 2014 Apr; 9(4):1444-52. PubMed ID: 24549567
[TBL] [Abstract][Full Text] [Related]
38. The PDZ protein GIPC regulates trafficking of the LPA1 receptor from APPL signaling endosomes and attenuates the cell's response to LPA.
Varsano T; Taupin V; Guo L; Baterina OY; Farquhar MG
PLoS One; 2012; 7(11):e49227. PubMed ID: 23145131
[TBL] [Abstract][Full Text] [Related]
39. Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors.
Hains MD; Wing MR; Maddileti S; Siderovski DP; Harden TK
Mol Pharmacol; 2006 Jun; 69(6):2068-75. PubMed ID: 16554409
[TBL] [Abstract][Full Text] [Related]
40. GPR35 is a novel lysophosphatidic acid receptor.
Oka S; Ota R; Shima M; Yamashita A; Sugiura T
Biochem Biophys Res Commun; 2010 Apr; 395(2):232-7. PubMed ID: 20361937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
